1
|
Long F, Yang D, Wang J, Wang Q, Ni T, Wei G, Zhu Y, Liu X. SMYD3-PARP16 axis accelerates unfolded protein response and mediates neointima formation. Acta Pharm Sin B 2021; 11:1261-1273. [PMID: 34094832 PMCID: PMC8148056 DOI: 10.1016/j.apsb.2020.12.010] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2020] [Revised: 08/24/2020] [Accepted: 10/13/2020] [Indexed: 12/12/2022] Open
Abstract
Neointimal hyperplasia after vascular injury is a representative complication of restenosis. Endoplasmic reticulum (ER) stress-induced unfolded protein response (UPR) is involved in the pathogenesis of vascular intimal hyperplasia. PARP16, a member of the poly(ADP-ribose) polymerases family, is correlated with the nuclear envelope and the ER. Here, we found that PERK and IRE1α are ADP-ribosylated by PARP16, and this might promote proliferation and migration of smooth muscle cells (SMCs) during the platelet-derived growth factor (PDGF)-BB stimulating. Using chromatin immunoprecipitation coupled with deep sequencing (ChIP-seq) analysis, PARP16 was identified as a novel target gene for histone H3 lysine 4 (H3K4) methyltransferase SMYD3, and SMYD3 could bind to the promoter of Parp16 and increased H3K4me3 level to activate its host gene's transcription, which causes UPR activation and SMC proliferation. Moreover, knockdown either of PARP16 or SMYD3 impeded the ER stress and SMC proliferation. On the contrary, overexpression of PARP16 induced ER stress and SMC proliferation and migration. In vivo depletion of PARP16 attenuated injury-induced neointimal hyperplasia by mediating UPR activation and neointimal SMC proliferation. This study identified SMYD3-PARP16 is a novel signal axis in regulating UPR and neointimal hyperplasia, and targeting this axis has implications in preventing neointimal hyperplasia related diseases.
Collapse
Key Words
- ATF6, activating transcription factor 6
- BIP, immunoglobulin heavy-chain binding protein
- ChIP-seq, chromatin immunoprecipitation coupled with deep sequencing
- DAPI, 4′,6-diamidino-2-phenylindole
- ECM, extracellular matrix
- EGCG, epigallocatechin-3-gallate
- ER, endoplasmic reticulum
- Endoplasmic reticulum
- H3K4, histone H3 lysine 4
- IACUC, Institutional Animal Care and Use Committee
- IRE1, inositol-requiring enzyme 1
- MMP, matrix metal proteinase
- Neointimal hyperplasia
- PARP, poly(ADP-ribose) polymerases
- PARP16
- PCNA, proliferating cell nuclear antigen
- PDGF, platelet-derived growth factor
- PERK, protein kinase R (PKR)-like ER kinase
- SMCs, smooth muscle cells
- SMYD3
- SMYD3, SET and MYND domain containing 3
- UPR, unfolded protein response
- VCAM-1, vascular cell adhesion molecule-1
- VSMCs, vascular smooth muscle cells
- Vascular smooth muscle cell
- XBP-1, X-box binding protein-1
- p-PERK, phosphate-PKR-like ER kinase
- p-eIF2α, phosphate-eukaryotic initiation factor 2α
- siRNA, small interfering RNA
Collapse
|
2
|
Du W, Zhu J, Zeng Y, Liu T, Zhang Y, Cai T, Fu Y, Zhang W, Zhang R, Liu Z, Huang JA. KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway. Cell Death Differ 2021; 28:1284-1300. [PMID: 33139930 PMCID: PMC8027631 DOI: 10.1038/s41418-020-00651-5] [Citation(s) in RCA: 50] [Impact Index Per Article: 16.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2020] [Revised: 10/13/2020] [Accepted: 10/15/2020] [Indexed: 01/30/2023] Open
Abstract
In addition to the role of programmed cell death ligand 1 (PD-L1) in facilitating tumour cells escape from immune surveillance, it is considered as a crucial effector in transducing intrinsic signals to promote tumour development. Our previous study has pointed out that PD-L1 promotes non-small cell lung cancer (NSCLC) cell proliferation, but the mechanism remains elusive. Here we first demonstrated that PD-L1 expression levels were positively correlated with p-MerTK levels in patient samples and NSCLC cell lines. In addition, PD-L1 knockdown led to the reduced phosphorylation level of MerTK in vitro. We next showed that PD-L1 regulated NSCLC cell proliferation via Gas6/MerTK signaling pathway in vitro and in vivo. To investigate the underlying mechanism, we unexpectedly found that PD-L1 translocated into the nucleus of cancer cells which was facilitated through the binding of Karyopherin β1 (KPNB1). Nuclear PD-L1 (nPD-L1), coupled with transcription factor Sp1, regulated the synthesis of Gas6 mRNA and promoted Gas6 secretion to activate MerTK signaling pathway. Taken together, our results shed light on the novel role of nPD-L1 in NSCLC cell proliferation and reveal a new molecular mechanism underlying nPD-L1-mediated Gas6/MerTK signaling activation. All above findings provide the possible combinational implications for PD-L1 targeted immunotherapy in the clinic.
Collapse
Affiliation(s)
- Wenwen Du
- grid.429222.d0000 0004 1798 0228Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, 215006 Suzhou, China ,Suzhou Key Laboratory for Respiratory Diseases, 215006 Suzhou, China
| | - Jianjie Zhu
- grid.429222.d0000 0004 1798 0228Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, 215006 Suzhou, China ,Suzhou Key Laboratory for Respiratory Diseases, 215006 Suzhou, China ,grid.263761.70000 0001 0198 0694Institute of Respiratory Diseases, Soochow University, 215006 Suzhou, China
| | - Yuanyuan Zeng
- grid.429222.d0000 0004 1798 0228Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, 215006 Suzhou, China ,Suzhou Key Laboratory for Respiratory Diseases, 215006 Suzhou, China ,grid.263761.70000 0001 0198 0694Institute of Respiratory Diseases, Soochow University, 215006 Suzhou, China
| | - Ting Liu
- grid.429222.d0000 0004 1798 0228Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, 215006 Suzhou, China ,Suzhou Key Laboratory for Respiratory Diseases, 215006 Suzhou, China
| | - Yang Zhang
- grid.429222.d0000 0004 1798 0228Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, 215006 Suzhou, China ,Suzhou Key Laboratory for Respiratory Diseases, 215006 Suzhou, China
| | - Tingting Cai
- grid.429222.d0000 0004 1798 0228Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, 215006 Suzhou, China ,Suzhou Key Laboratory for Respiratory Diseases, 215006 Suzhou, China
| | - Yulong Fu
- grid.429222.d0000 0004 1798 0228Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, 215006 Suzhou, China ,Suzhou Key Laboratory for Respiratory Diseases, 215006 Suzhou, China
| | - Weijie Zhang
- grid.429222.d0000 0004 1798 0228Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, 215006 Suzhou, China ,Suzhou Key Laboratory for Respiratory Diseases, 215006 Suzhou, China
| | - Ruochen Zhang
- grid.429222.d0000 0004 1798 0228Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, 215006 Suzhou, China ,Suzhou Key Laboratory for Respiratory Diseases, 215006 Suzhou, China
| | - Zeyi Liu
- grid.429222.d0000 0004 1798 0228Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, 215006 Suzhou, China ,Suzhou Key Laboratory for Respiratory Diseases, 215006 Suzhou, China ,grid.263761.70000 0001 0198 0694Institute of Respiratory Diseases, Soochow University, 215006 Suzhou, China
| | - Jian-an Huang
- grid.429222.d0000 0004 1798 0228Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, 215006 Suzhou, China ,Suzhou Key Laboratory for Respiratory Diseases, 215006 Suzhou, China ,grid.263761.70000 0001 0198 0694Institute of Respiratory Diseases, Soochow University, 215006 Suzhou, China
| |
Collapse
|
3
|
Wang CL, Tang Y, Li M, Xiao M, Li QS, Yang L, Li X, Yin L, Wang YL. Analysis of Mono-ADP-Ribosylation Levels in Human Colorectal Cancer. Cancer Manag Res 2021; 13:2401-2409. [PMID: 33737837 PMCID: PMC7965690 DOI: 10.2147/cmar.s303064] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2021] [Accepted: 02/25/2021] [Indexed: 01/05/2023] Open
Abstract
BACKGROUND Colorectal cancer remains a major public health problem with high morbidity and mortality rates. In the search for the mechanisms of colorectal cancer occurrence and development, increasing attention has been focused on epigenetics. The overall level of Mono-ADP-ribosylation, an epigenetic, has not been investigated now. The aim of our study was to analysis of the overall level of mono-ADP-ribosylation in colorectal cancer. METHODS Immunohistochemistry was used to investigate the level of mono-ADP-ribosylation in colorectal cancer and normal colorectal adjacent tissue from 64 CRC patients. The data of patient demographic, clinical and pathological characteristics were acquired and analyzed. RESULTS Mono-ADP-ribosylation was present in both colorectal adenocarcinoma and normal colorectal tissue. The overall level of mono-ADP-ribosylation in colorectal cancer was significantly higher than that in normal colorectal adjacent tissue. In the nucleus, the majority of samples in the high-level group were colorectal adenocarcinoma (55/64), but the opposite was true for normal colorectal tissues (7/32). In particular, increases in the level of mono-ADP-ribosylation in the cytoplasm of colorectal cancer cells was associated with a greater invasion depth of the tumor. CONCLUSION The increased level of mono-ADP-ribosylation in colorectal cancer enhances tumor invasion, which suggests that mono-ADP-ribosylation is involved in the development of colorectal cancer and may become a new direction to solve the problem of colorectal cancer.
Collapse
Affiliation(s)
- Chuan-Ling Wang
- Department of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, 400016, People’s Republic of China
| | - Yi Tang
- Department of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, 400016, People’s Republic of China
| | - Ming Li
- Department of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, 400016, People’s Republic of China
| | - Ming Xiao
- Department of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, 400016, People’s Republic of China
| | - Qing-Shu Li
- Department of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, 400016, People’s Republic of China
| | - Lian Yang
- Department of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, 400016, People’s Republic of China
| | - Xian Li
- Department of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, 400016, People’s Republic of China
| | - Ling Yin
- Department of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, 400016, People’s Republic of China
| | - Ya-Lan Wang
- Department of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, 400016, People’s Republic of China
| |
Collapse
|
4
|
Hill JM, Clement C, Zhao Y, Lukiw WJ. Induction of the pro-inflammatory NF-kB-sensitive miRNA-146a by human neurotrophic viruses. Front Microbiol 2015; 6:43. [PMID: 25691883 PMCID: PMC4315103 DOI: 10.3389/fmicb.2015.00043] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2014] [Accepted: 01/12/2015] [Indexed: 01/13/2023] Open
Affiliation(s)
- James M Hill
- Departments of Microbiology and Pharmacology, Louisiana State University Health Science Center New Orleans, LA, USA ; LSU Neuroscience Center and Department of Ophthalmology, Louisiana State University Health Science Center New Orleans, LA, USA
| | - Christian Clement
- Infectious Diseases, Experimental Therapeutics and Human Toxicology Lab, Department of Natural Sciences, Southern University at New Orleans New Orleans, LA, USA
| | - Yuhai Zhao
- LSU Neuroscience Center and Department of Ophthalmology, Louisiana State University Health Science Center New Orleans, LA, USA
| | - Walter J Lukiw
- LSU Neuroscience Center and Department of Ophthalmology, Louisiana State University Health Science Center New Orleans, LA, USA ; Department of Neurology, Louisiana State University Health Science Center New Orleans, LA, USA
| |
Collapse
|